Schonfeld Strategic Advisors

Inventiva Pharma is a clinical-stage biopharmaceutical company based in France, dedicated to developing oral small molecule therapies aimed at addressing significant unmet medical needs in fibrosis, lysosomal storage disorders, and oncology. The company has established a robust pipeline supported by a proprietary discovery engine and a wholly-owned research and development facility. It possesses an extensive library of molecules and a team with considerable expertise in developing compounds that target nuclear receptors, transcription factors, and epigenetic modulation. Inventiva is advancing clinical candidates, including lanifibranor, which is being developed for non-alcoholic steatohepatitis (NASH), a condition currently lacking approved treatments. Additionally, the company is engaged in a variety of pre-clinical therapy programs, further strengthening its portfolio in the fields of oncology, fibrosis, and rare diseases.

Outlook Therapeutics, Inc. is a late clinical-stage biopharmaceutical company dedicated to the development and commercialization of monoclonal antibodies for ophthalmic conditions. The company's primary focus is on its lead product candidate, ONS-5010, a proprietary ophthalmic formulation of bevacizumab, currently undergoing Phase-III clinical trials aimed at treating wet age-related macular degeneration and other retinal diseases. Outlook Therapeutics has established collaboration and licensing agreements with several international partners, including IPCA Laboratories Limited and Laboratorios Liomont, S.A. de C.V. Originally incorporated as Oncobiologics, Inc. in 2010, the company rebranded to Outlook Therapeutics, Inc. in November 2018 and is headquartered in Cranbury, New Jersey.

Bolt is a company dedicated to enhancing e-commerce by providing a streamlined checkout experience. Founded in 2014 and headquartered in San Francisco, Bolt offers a platform that enables retailers to facilitate secure, one-click checkouts for their customers, eliminating the need for passwords or repeated personal information. This approach not only simplifies the purchasing process but also improves conversion rates and customer retention for businesses. A growing number of retailers, including well-known brands such as REVOLVE, Casper, Badgley Mischka, and Benefit Cosmetics, utilize Bolt's services to meet the demand for efficient and user-friendly online shopping experiences. By democratizing commerce, Bolt aims to strengthen the connection between retailers and their customers.

Inxeption Corporation is a South San Francisco-based company that operates a cloud-based e-commerce platform tailored for the industrial and supply chain sectors. Founded in 2017, Inxeption provides a suite of tools and blockchain technology designed to facilitate the promotion, sale, and management of products and services online. Its platform offers features such as PRODUCT LEDGER, which digitizes and centralizes product information, and enables businesses of all sizes to enhance sales, gain operational visibility, and achieve cost efficiencies. Additionally, Inxeption Commerce Partners can access a B2B marketplace to sell products and develop new online commerce channels, as well as utilize applications that streamline logistics and other operational processes. The company aims to improve business practices within the industrial sector by promoting a more efficient approach to commerce.

Innovaccer Inc. is a technology company that specializes in developing analytical and data science applications primarily for the healthcare sector, along with industries such as financial services, manufacturing, and retail. The company offers a comprehensive Healthcare Intelligence Cloud that aggregates and analyzes patient data from various sources, including electronic health records and medical devices, to provide actionable insights. Its suite of solutions includes Datashop, which encompasses tools for patient care management, risk assessment in financial markets, and healthcare trend analysis. Innovaccer's platforms facilitate improved clinical workflows, care coordination, and operational efficiency by integrating functionalities for population health management and billing processes. Founded in 2012 and headquartered in Noida, India, with an office in Palo Alto, California, Innovaccer serves a diverse clientele, including academic institutions and governmental organizations, both domestically and internationally.

Automattic Inc., established in 2005 and headquartered in San Francisco, specializes in developing and providing web-based solutions. It is renowned for its suite of products, including WordPress.com for website creation and management, WooCommerce for e-commerce, and Jetpack for site performance and security. Automattic serves non-profit and open-source projects globally, with a mission to democratize publishing and commerce through its open-source content management systems.

Unqork Inc. is a New York-based company that operates a no-code enterprise application platform designed to assist organizations in developing, deploying, and managing complex custom software applications. Founded in 2016, Unqork's platform eliminates the need for coding, enabling users in sectors such as financial services, insurance, real estate, government, education, and healthcare to create high-quality applications more efficiently and at a lower cost than traditional methods. By streamlining the product sales process and enhancing customer experience, Unqork empowers large enterprises to quickly build and implement tailored solutions that meet their specific needs.

Poseida Therapeutics, Inc. is a clinical-stage biopharmaceutical company based in San Diego, California, dedicated to developing innovative therapeutics for patients with significant unmet medical needs. The company specializes in genome engineering technologies and is focused on creating targeted treatments, including a pipeline of autologous and allogeneic chimeric antigen receptor T cell (CAR-T) therapies aimed at addressing hematological malignancies and solid tumors. Additionally, Poseida is advancing gene therapies for rare and life-threatening diseases, such as Ornithine transcarbamylase deficiency and methylmalonic acidemia, along with therapies for genetic liver diseases. Founded in 2014, Poseida Therapeutics is committed to improving patient outcomes through its cutting-edge research and development efforts.

AvidXchange, Inc. is a leading provider of accounts payable automation and payment solutions specifically designed for mid-sized companies in various sectors, including banking, construction, healthcare, hospitality, real estate, and technology. Founded in 2000 and headquartered in Charlotte, North Carolina, AvidXchange streamlines invoice and payment processes, processing over $140 billion in transactions annually through a network of more than 680,000 suppliers. The company's comprehensive software suite includes tools for purchase order management, invoice handling, payment processing, check printing, and utility bill management. With a workforce of approximately 1,500 employees and additional offices in several states, AvidXchange has established itself as a prominent player in the fintech space, transforming how approximately 6,000 customers across North America manage their accounts payable and payment workflows.